Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping

Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping

Background: The Food and Drug Administration (FDA) in the US approved primary human papillomavirus (HPV) testing for speculum-based cervical cancer screening ten years ago and, in May 2024, approved the self-collection technique. Our study defines the kappa agreement between self- and speculum-based...

Full description

Saved in:
Bibliographic Details
Main Authors: Alisa P. Young, Mutiya Olorunfemi, Leigh Morrison, Scott A. Kelley, Anna Laurie, Anna McEvoy, Jill Schneiderhan, Julie Prussack, Marie Claire O'Dwyer, Pamela Rockwell, Philip Zazove, Jonathan Gabison, Jane Chargot, Kristina Gallagher, Ananda Sen, Dongru Chen, Elizabeth A. Haro, Emma A. Butcher, Martha L. Alves, Christelle El Khoury, Melinda L. Dendrinos, Nicole Brashear, Roger Smith, Richard W. Lieberman, Natalie Saunders, Elizabeth Campbell, Heather M. Walline, Diane M. Harper
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Preventive Medicine Reports
Subjects:
Cervical cancer screening
Self-sampling.
Primary HPV screening.
Agreement.
Kappa.
Sensitivity.
Online Access:http://www.sciencedirect.com/science/article/pii/S2211335525000105
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2211335525000105

Similar Items